Table 3 Proportion of patients treated with each medication class out of those receiving first-line therapy (includes mono- or combination therapy)
CCAE (N = 80,810) | MDCD (N = 33,186) | MDCR (N = 3764) | Optum (N = 51,585) | |||||
|---|---|---|---|---|---|---|---|---|
SSRI | 46,432 | 57.5% | 12,035 | 36.3% | 1693 | 45.0% | 25,942 | 50.3% |
Anxiolytic | 14,625 | 18.1% | 6141 | 18.5% | 695 | 18.5% | 9095 | 17.6% |
Other antidepressant | 12,196 | 15.1% | 3578 | 10.8% | 518 | 13.8% | 7438 | 14.4% |
Hypnotic/Sedative | 6981 | 8.6% | 666 | 2.0% | 99 | 2.6% | 1218 | 2.4% |
Anticonvulsant | 7377 | 9.1% | 1813 | 5.5% | 514 | 13.7% | 5855 | 11.4% |
SNRI | 4531 | 5.6% | 966 | 2.9% | 249 | 6.6% | 3145 | 6.1% |
Antipsychotic | 4609 | 5.7% | 2120 | 6.4% | 275 | 7.3% | 2944 | 5.7% |
Tricyclic | 1426 | 1.8% | 842 | 2.5% | 61 | 1.6% | 926 | 1.8% |
Stimulant | 1048 | 1.3% | 426 | 1.3% | 19 | 0.5% | 1537 | 3.0% |
Lithium | 246 | 0.3% | 106 | 0.3% | 2 | 0.1% | 110 | 0.2% |
MAOI | 7 | 0.0% | 2 | 0.0% | 3 | 0.1% | 16 | 0.0% |